Xilio Therapeutics, Inc. (XLO): Depreciation & Amortization
$1.54M
Year ended 2025-12-31
$1.34M
Trailing 12 months to 2026-06-30
-5.9%
3-year compound annual growth
+7.7%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.54M | -6.3% | 2026-03-23, From 2025-01-01 |
| 2024-12-31 | $1.64M | -13.5% | 2026-03-23, From 2024-01-01 |
| 2023-12-31 | $1.90M | +2.9% | 2025-03-11, From 2023-01-01 |
| 2022-12-31 | $1.85M | +23.2% | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | $1.50M | +40.8% | 2023-03-02, From 2021-01-01 |
| 2020-12-31 | $1.06M | n/a | 2022-03-01, From 2020-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Xilio Therapeutics, Inc. (XLO) | 2025-12-31 | $1.54M | -6.3% |
| Cumberland Pharmaceuticals Inc (CPIX) | 2025-12-31 | $4.15M | -15.4% |
| Aquestive Therapeutics, Inc. (AQST) | 2025-12-31 | $548.0K | -23.7% |
| Biofrontera Inc. (BFRI) | 2025-12-31 | $138.0K | -67.2% |
| Septerna, Inc. (SEPN) | 2025-12-31 | $1.60M | +14.3% |
| Protagonist Therapeutics, Inc (PTGX) | 2025-12-31 | $1.28M | +55.0% |
| Gossamer Bio, Inc. (GOSS) | 2025-12-31 | $24.0K | -97.1% |
| Lexicon Pharmaceuticals, Inc. (LXRX) | 2025-12-31 | $621.0K | +16.3% |
| BGM Group Ltd. (BGM) | 2025-09-30 | $1.46M | +18.3% |
Compare XLO, CPIX, AQST, BFRI side by side · Screen every company in Pharmaceutical Preparations ↗